reference/1631612

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/1631612

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Clinical Trial, Phase I\|Journal Article\|Multicenter Study\|Randomized Controlled Trial\|Research Support, U.S. Gov't, P.H.S.
endingPage	1656
issn	1078-0432 1557-3265
issueIdentifier	5
pageRange	1645-1656
publicationName	Clinical cancer research : an official journal of the American Association for Cancer Research
startingPage	1645
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_5a0eb2fadabf1dffb4d70280b760adba http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_a67ceaf67e4a3e0ba5b3b4304121c535 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_75b18fbb58b133994b8f8785488a6c36 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_94a75d548f47cc8add65bcfac00c633b
bibliographicCitation	Hammond LA, Eckardt JR, Kuhn JG, Gerson SL, Johnson T, Smith L, Drengler RL, Campbell E, Weiss GR, Von Hoff DD, Rowinsky EK. A randomized phase I and pharmacological trial of sequences of 1,3-bis(2-chloroethyl)-1-nitrosourea and temozolomide in patients with advanced solid neoplasms. Clin Cancer Res. 2004 Mar 01;10(5):1645–56. doi: 10.1158/1078-0432.ccr-03-0174. PMID: 15014015.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0cc4ec1bd0683e6c6d10588d4884b732 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0545c22b2407187e8d063f959b572b3a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_286391809fb6d4719e361c6a7239a705 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b40638dd63f6752655b6a40062882bf9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bbf2ff4e1eed273109f5b7441cb17f33 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a5b44264e542072c3c38f05e37ceef37 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_21ada525e110fe4614f227a9357bd3c1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_33cded4c9ae0ed0bbb723f06022a7f4a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_71d8228a2cca36b880bb58f482c44bb6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_aac2ca691a7575179127ea355a620e58 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b5796663ddc2a0959a1660f358bd7a45
date	2004-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1158/1078-0432.ccr-03-0174 https://pubmed.ncbi.nlm.nih.gov/15014015
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/8794 https://portal.issn.org/resource/ISSN/1557-3265 https://portal.issn.org/resource/ISSN/1078-0432
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	A Randomized Phase I and Pharmacological Trial of Sequences of 1,3-bis(2-Chloroethyl)-1-Nitrosourea and Temozolomide in Patients with Advanced Solid Neoplasms
discusses	http://id.nlm.nih.gov/mesh/M0003490 http://id.nlm.nih.gov/mesh/M0005636 http://id.nlm.nih.gov/mesh/M0136562
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000971Q000633 http://id.nlm.nih.gov/mesh/D003606Q000031 http://id.nlm.nih.gov/mesh/D002330Q000633 http://id.nlm.nih.gov/mesh/D009369Q000188 http://id.nlm.nih.gov/mesh/D003606Q000633
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D009504Q000187 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D009504Q000473 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D001792Q000187 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D002330Q000493 http://id.nlm.nih.gov/mesh/D001792Q000473 http://id.nlm.nih.gov/mesh/D000369 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D009369Q000473 http://id.nlm.nih.gov/mesh/D002330Q000008 http://id.nlm.nih.gov/mesh/D003606Q000008 http://id.nlm.nih.gov/mesh/D003606Q000493 http://id.nlm.nih.gov/mesh/D005500 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D000077204 http://id.nlm.nih.gov/mesh/D004305 http://id.nlm.nih.gov/mesh/D000328
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID105035 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9408 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7156 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9149 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5394 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2578 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7838 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6918763 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8661

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127548128 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128856490 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127830723 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127750960

Total number of triples: 77.